Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


03.12.2018

1 Enferm Infecc Microbiol Clin
4 J Hepatol
1 J Infect Dis
1 J Virol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Enferm Infecc Microbiol Clin

  1. MARTIN-CARBONERO L, Dominguez-Dominguez L, Bailon L, Torres R, et al
    Effect of mono/dual antiretroviral therapy on suppression of HCV and HIV during treatment of HCV infection in HIV/HCV-coinfected patients.
    Enferm Infecc Microbiol Clin. 2018 Nov 23. pii: S0213-005X(18)30277.
    PubMed     Text format     Abstract available


    J Hepatol

  2. MODIN L, Arshad A, Wilkes B, Benselin J, et al
    Epidemiology and natural history of hepatitis C virus infection among children and young people.
    J Hepatol. 2018 Nov 26. pii: S0168-8278(18)32545.
    PubMed     Text format     Abstract available

  3. VAN SEYEN M, Smolders EJ, van Wijngaarden P, Drenth JPH, et al
    Successful HCV treatment of patients on contraindicated anti-epileptic drugs: Role of drug level monitoring.
    J Hepatol. 2018 Nov 22. pii: S0168-8278(18)32492.
    PubMed     Text format    

  4. D'AMBROSIO R, Pasulo L, Puoti M, Vinci M, et al
    Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in 723 patients with chronic hepatitis C.
    J Hepatol. 2018 Nov 22. pii: S0168-8278(18)32543.
    PubMed     Text format     Abstract available

  5. COSTA R, Todt D, Zapatero-Belinchon F, Schenk C, et al
    SEC14L2, a lipid-binding protein, regulate HCV replication in culture with inter- and intra- genotype variations.
    J Hepatol. 2018 Nov 22. pii: S0168-8278(18)32544.
    PubMed     Text format     Abstract available


    J Infect Dis

  6. PIROZYAN MR, Nguyen N, Cameron B, Luciani F, et al
    Chemokine-regulated recruitment of antigen-specific T cell sub-populations to the liver in acute and chronic hepatitis C infection.
    J Infect Dis. 2018 Nov 29. pii: 5213654. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  7. VELAZQUEZ-MOCTEZUMA R, Galli A, Law M, Bukh J, et al
    Hepatitis C virus escape studies for human antibody AR3A reveals a high barrier to resistance and novel insights on viral antibody evasion mechanisms.
    J Virol. 2018 Nov 28. pii: JVI.01909-18. doi: 10.1128/JVI.01909.
    PubMed     Text format     Abstract available


    PLoS One

  8. KHAN B, Duncan I, Saad M, Schaefer D, et al
    Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment.
    PLoS One. 2018;13:e0206356.
    PubMed     Text format     Abstract available

  9. BUTI M, Dominguez-Hernandez R, Casado MA, Sabater E, et al
    Healthcare value of implementing hepatitis C screening in the adult general population in Spain.
    PLoS One. 2018;13:e0208036.
    PubMed     Text format     Abstract available

  10. CHOWDHURY P, Sahuc ME, Rouille Y, Riviere C, et al
    Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture.
    PLoS One. 2018;13:e0198226.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: